Navigation Links
Pharmasset Reports Fiscal Second Quarter 2011 Financial Results

d Exchange Commission and discussions of potential risks, uncertainties, and other important factors in our subsequent filings with the Securities and Exchange Commission.PHARMASSET, INC.CONDENSED STATEMENTS OF OPERATIONS(UNAUDITED)(in thousands, except share and per share amounts)Three Months EndedMarch 31,20112010Revenues

251COSTS AND EXPENSES:  Research and development

16,99512,028  General and administrative

3,7733,647Total costs and expenses

20,76815,675Operating loss

(20,521)(15,424)Investment income

11Other income

--Interest expense

(310)(638)Loss before income taxes

(20,830)(16,061)Provision (benefit) for income taxes

(973)-Net loss

(16,061)Net loss per share: basic and diluted

(0.54)Weighed average shares outstanding:basic and diluted

36,293,89829,522,630PHARMASSET, INC.BALANCE SHEETS(in thousands, except par value, share and per share amounts)As ofAs ofMarch 31,September 30,20112010(unaudited)ASSETSCURRENT ASSETS:  Cash and cash equivalents

$ 208,317

$ 127,081  Amounts due from collaboration partner


6  Prepaid expenses and other current assets


718Total current assets




4,060  Leasehold improvements



5,897  Less accumulated depreciation and amortization


(4,184)Total equipment and leasehold improvements, net


1,713Restricted cash


100Other assets



$ 211,489



8,705  Accounts payable


5,037  Accrued expenses


5,863  De

SOURCE Pharmasset, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
2. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
3. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
4. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
5. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
6. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
7. Pharmasset Reports First Fiscal Quarter 2008 Financial Results
8. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
9. Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
10. Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C
11. Pharmasset Receives Notice of Allowance
Post Your Comments:
(Date:10/9/2015)... 9, 2015 AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX ... the annual European Society of Emergency Medicine (EuSEM) meeting to ... , 2015 at the Lingotto Congress Centre in ... meeting of emergency medicine practitioners in the world with over ... Data from the previously announced phase 2 bunionectomy trial will ...
(Date:10/9/2015)... LAUSANNE , Suiza, October 9, 2015 El ... Yutaka Kondo y Junko Takita ... se ha otorgado a los doctores Yutaka Kondo ... El ,JCA-Mauvernay Award 2015, se ha otorgado a los ... Junko Takita    ™ , una compañía biofarmacéutica global con ...
(Date:10/8/2015)... 8, 2015  Ardelyx, Inc. (NASDAQ: ARDX ... and cardio-renal diseases, today announced that clinical data ... be presented at the 2015 American College of ... measures of sustained response in IBS-C patients enrolled ... Phase 2 trial. The meeting will be held ...
Breaking Medicine Technology:
(Date:10/9/2015)... ... October 09, 2015 , ... ... was recognized by Cabarrus County Active Living and Parks for its outstanding commitment ... company’s dedication to consistently going above and beyond the call of duty, ...
(Date:10/9/2015)... ... October 09, 2015 , ... ... Post, CPA , as Chief Financial Officer. Kimberly will provide leadership and ... with any strategic acquisitions. Kimberly’s experience guiding healthcare services organizations through significant ...
(Date:10/9/2015)... , ... October 09, 2015 , ... ... pleased to announce it will sponsor the upcoming Cisco Georgia Partner Appreciation Event. ... Complex on the campus of Georgia Tech, in Atlanta, Georgia. , This year’s ...
(Date:10/8/2015)... ... October 09, 2015 , ... The Guthrie ... this November. The support post-concussion group was started by Steven Hicks, a Licensed ... member. The group was started in November 2010 to help support ...
(Date:10/8/2015)... ... October 08, 2015 , ... Florida Hospital, the Exclusive Hospital of the Tampa ... 5K Run/Walk benefitting breast cancer research and patient services. The race is expected to ... 11th at Raymond James Stadium prior to the Bucs game versus the Jacksonville Jaguars, ...
Breaking Medicine News(10 mins):
... an inherited disease that clogs airways with thick mucous, ... life expectancy for children with cystic fibrosis has increased ... shortened in young adulthood by the ravages of lung ... common, environmental microbes that mutate in ways that let ...
... are offering pediatric patients diagnosed with chronic illnesses acupuncture ... effects like nausea, fatigue, and vomiting caused by chronic ... Chinese and Western medicine at Rush Children,s Hospital is ... acupuncture might help in reducing pain in children and ...
... ... to address childhood obesity, a risk factor for a number of chronic diseases including diabetes, ... ... today launched a major campaign to address childhood obesity, a risk factor for a number ...
... , ... Sunquest Collection Manager™ increases patient safety through accuracy and timeliness , ... (PRWEB) February 9, ... and outreach solutions, announced today that the University of Virginia Health System Medical ...
... recurrence-free, research shows , TUESDAY, Feb. 9 (HealthDay News) ... play a part in prognosis with non-small cell lung cancers, ... of the patient. , The researchers analyzed genetic and clinical ... on sex and age (below or above age 70). The ...
... begins in the womb, expert says, , TUESDAY, Feb. 9 ... of milk and have a high dietary intake of vitamin ... multiple sclerosis later in life, researchers say. , The new ... their experiences and diet during pregnancy. The nurses were followed ...
Cached Medicine News:
... Anatomical Malar I Implants - Providing the ... follows the contour of the zygoma while ... Anatomical Malar II Implants - The ... surgeon with another augumentation option that adds ...
Chin Implants are used for cosmetic augmentation, repairing trauma related injuries and genetic deficiencies. They are inserted through an incision in the mouth below the incisor teeth or through an ...
... FL40 Centrifuge Series from Thermo Electron ... increase your productivity in the lab. ... rotors and accessories for high-volume blood ... IEC CL40 and FL40 Centrifuge Series ...
Medicine Products: